MOLOGEN applies for clinical study with cell-based gene therapy for renal cancer - PipelineReview.com (press release) |
![]() |
PipelineReview.com (press release)MGN1601 is a cell-based gene therapy for the treatment of advanced renal cancer. The purpose of this phase I/II clinical study (ASET study) is to ... read more |